# Pravastatin for Hyperlipidaemia in HIV.

> **NCT00227500** · PHASE4 · COMPLETED · sponsor: **Kirby Institute** · enrollment: 40 (—)

## Conditions studied

- HIV Infections
- Lipid Metabolism
- Glucose Metabolism
- Metabolic Abnormality
- Lipodystrophy
- Cardiovascular Disease

## Interventions

- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT00227500
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-06-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227500, "Pravastatin for Hyperlipidaemia in HIV.". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00227500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*